Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.
Ida Holte ThoriusLise Lotte N HusemoenRikke Baastrup NordsborgAmra C AlibegovicMari-Anne GallJanne PetersenPeter DammElisabeth Reinhardt MathiesenPublished in: Diabetes care (2023)
Insulin pump treatment in pregnant women with T1D, prior to the widespread use of continuous glucose monitoring or automated insulin delivery, was associated with a higher risk of LGA offspring and preterm delivery compared with MDI in crude and adjusted analyses. This association did not appear to be mediated by differences in glycemic control as represented by HbA1c or by gestational weight gain.
Keyphrases
- glycemic control
- weight gain
- type diabetes
- weight loss
- birth weight
- blood glucose
- body mass index
- gestational age
- insulin resistance
- low birth weight
- pregnant women
- preterm birth
- physical activity
- polycystic ovary syndrome
- machine learning
- pregnancy outcomes
- deep learning
- high throughput
- ultrasound guided
- breast cancer risk